Search - Université de Rennes Access content directly

Filter your results

5 Results
authFullName_s : Jerome Dumortier

Achieving SVR Does Not Prevent From Fibrosis Progression In Patients With FCH: Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort

Mylene Sebagh , Claire Fougerou-Leurent , Georges-Philippe Pageaux , Vincent Leroy , Jerome Dumortier et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles hal-01684629v1

Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort

Mylene Sebagh , Claire Fougerou-Leurent , Georges-Philippe Pageaux , Vincent Leroy , Jerome Dumortier et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles hal-01769633v1

EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT

Fabien Zoulim , Claire Fougerou , Roulot Marullo Dominique , Sophie Metivier , Victor de Ledinghen et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles hal-03922586v1
Image document

Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation results from the CO23 ANRS CUPILT study

Jerome Dumortier , V. Leroy , C. Duvoux , V. De Lédinghen , C. Francoz et al.
Liver Transplantation, 2016, 22 (10), pp.1367--1378. ⟨10.1002/lt.24505⟩
Journal articles hal-01397762v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1